BioSpace News Archive

Rising adoption of robotics and process automation in various business verticals, especially in healthcare sector is the prime reason for the growth of global electronic lab notebook market.

Aptorum Group Limited announced that Mr. Darren Lui, President and Executive Director of Aptorum Group, and Dr. Herman Weiss, CEO and Executive Director of Claves Life Sciences Limited and Senior Medical Advisor of Aptorum Group, will present at the LD 500 investor conference and H.C. Wainwright 22nd Annual Global Life Sciences Conference in September.

Patient enrollment to the company’s exploratory clinical studies was resumed in May after a temporary pause due to the COVID-19 pandemic

Aptorum Group Limited, a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announced that it will be presenting at the LD 500 investor conference on Tuesday, September 1 at 9:20 AM EST.

What’s New: Intel announced that it is among the leading U.S. quantum technology companies included in Q-NEXT, one of five new national quantum research centers established by the White House Office of Science and Technology Policy and the U.S. Department of Energy.

TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, in conjunction with 3SBio, announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted its Marketing Authorization Application for Ampholipad™, TLC’s complex generic of Gilead’s AmBisome® used for the treatment of systemic fungal infections.

Early intervention programs to be implemented at 13 of Canada’s children’s hospitals for children, youth and families struggling with mental health challenges

Funding completes $82 million Series B round with the addition of $19 million, will further accelerate Aetion’s role as a global leader in regulatory-grade evidence

DHS , Department of Transportation , FEMA , State Department , Military , and other agencies are engaged in mitigating coronavirus spread and its public safety implications. High-traffic areas on military bases, government buildings, research

Emergent BioSolutions Inc. announced that the company’s board of directors appointed Marvin L. White as a Class II director to serve on the board effective October 1, 2020, with an initial term expiring at the 2023 annual meeting of stockholders.